RYSUPEN Trademark

Trademark Overview

On Wednesday, June 9, 2021, a trademark application was filed for RYSUPEN with the United States Patent and Trademark Office. The USPTO has given the RYSUPEN trademark a serial number of 90764606. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, May 6, 2024. This trademark is owned by Amneal Pharmaceuticals LLC. The RYSUPEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraine

General Information

Serial Number90764606
Word MarkRYSUPEN
Filing DateWednesday, June 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of migraine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmneal Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Saturday, June 12, 2021NEW APPLICATION ENTERED
Tuesday, June 29, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 29, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 29, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 26, 2022ASSIGNED TO EXAMINER
Monday, February 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 17, 2022SOU EXTENSION 1 FILED
Thursday, November 17, 2022SOU EXTENSION 1 GRANTED
Saturday, November 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 2 FILED
Tuesday, May 2, 2023SOU EXTENSION 2 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2023SOU EXTENSION 3 FILED
Tuesday, November 14, 2023SOU EXTENSION 3 GRANTED
Thursday, November 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024SOU EXTENSION 4 FILED
Monday, May 6, 2024SOU EXTENSION 4 GRANTED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

rysupen migraine treatment preparations pharmaceutical